Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster... Show more
LAB is expected to report earnings to fall 28.57% to -5 cents per share on August 06
Q2'25
Est.
$-0.05
Q1'25
Missed
by $0.01
Q4'24
Missed
by $0.02
Q3'24
Beat
by $0.02
Q2'24
Missed
by $0.04
The last earnings report on May 06 showed earnings per share of -7 cents, missing the estimate of -5 cents. With 127.58K shares outstanding, the current market capitalization sits at 1.04B.